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We present the prenatal diagnosis and molecular cytogenetic
characterization of a fetus associated with 22q13 deletion syn-
drome and congenital malformations.
A 32-year-old, gravida 2, para 1, woman was referred for
amniocentesis at 28 weeks of gestation because of abnormal pre-
natal ultrasound ﬁndings of right microtia, hemivertebrae of the
lumbar spine, ventricular septal defect, and total anomalous pul-
monary venous return. Amniocentesis revealed a karyotype of
46,XX,del(22)(q13.31q13.33). The parental karyotypes were
normal. Array comparative genomic hybridization analysis on un-
cultured amniocytes using Roche ISCA Plus Cytogenetic Array Chips
(Roche, Basel, Switzerland) revealed a 6.48-Mb deletion of
22q13.31-q13.33 or arr 22q13.31q13.33 (44,731,454e51,209,196)
1 (Figure 1). The deleted region encompasses 113 genes including
46 Online Mendelian Inheritance in Man (OMIM) genes of PRR5,
ARHGAP8, NUP50, UPK3A, SMC1B, FBLN1, ATXN10, WNT7B, MIR-
LET7A3, MIRLET7B, PPARA, PKDREJ, GTSE1, TRMU, CELSR1, GRAMD4,
CERK, BRD1, ZBED4, ALG12, CRELD2, PIM3, IL17REL, MLC1, MOV10L1,
PANX2, SELO, TUBGCP6, HDAC10,MAPK12,MAPK11, PLXNB2, PPP6R2,
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).ARSA, SHANK3, ACR and RABL2B. A 1170-g malformed female fetus
was subsequently delivered with right microtia and facial dys-
morphism of left large ear, full brow, dolichocephaly, full cheeks, a
bulbous nose, and a pointed chin.
PhelaneMcDermid syndrome (OMIM 606232) or 22q13 dele-
tion syndrome is characterized by normal to advanced growth
(91%), global developmental delay (96%), absent or severely delayed
speech (96%), hypotonia (89%), seizures (27%), sensorineural hear-
ing loss (8%), dolichocephaly (50%), ptosis (43%), epicanthic folds
(39%), prominent/dysplastic ears (58%), pointed chin (52%), ten-
dency to overheat/lack of perspiration (51%), relatively large ﬂeshy
hands (60%), ﬁfth-ﬁnger clinodactyly (13%), abnormal toenail
growth (79%), 2e3 syndactyly of toes (34%), cardiac anomalies (6%),
genitourinary anomalies (9%), increased tolerance to pain (86%),
frequent mouthing/chewing of objects (70%), and other manifes-
tations (<5%) of puffy swollen feet, arachnoid cysts, and increased
incidence of respiratory infections [1]. Haploinsufﬁciency of the
SHANK3 gene (OMIM 606230) has been known to be an important
factor responsible for the neurological symptoms of the 22q13
deletion syndrome such as hypotonia, developmental delay, absent
to delayed speech, and autistic behavior [2].
Prenatal diagnosis of pure 22q13 deletion due to abnormal fetal
ultrasound is very rare. The peculiar aspect of the present case is
the associated prenatal ultrasound ﬁndings of microtia, hemi-
vertebrae of the lumbar spine, and congenital heart defects. Riegel
et al [3] reported a fetus with mosaic del(22)(q13) at 21 weeks’
gestation due to fetal cystic thymus. Phelan et al [4] reported a
second-trimester prenatal diagnosis of mosaic 22q13.3 deletion
due to a positive maternal serum screening for Down syndrome,
and suggested that decreased fetal movement because of hypotonia
is an indicator of 22q13 deletion syndrome. Kirkpatrick and El-
Khechen [5] reported prenatal diagnosis of a terminal 22q13
deletion (22q13.31/q13.33) in a fetus with unilateral multicysticy Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND license
Figure 1. Array comparative genomic hybridization analysis shows a 6.48-Mb deletion of 22q13.31-22q13.33 or arr 22q13.31q13.33 (44,731,454e51,209,196)1 encompassing the
SHANK3 gene. (A) and (B) chromosome zoom-in view.
C.-P. Chen et al. / Taiwanese Journal of Obstetrics & Gynecology 55 (2016) 455e456456kidney, unilateral cleft lip, and polyhydramnios. The present case
additionally shows that deformities of the ears, spine, and cardio-
vascular structures can be prenatal ultrasound abnormalities
associated with 22q13 deletion syndrome.
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